megestrol acetate has been researched along with sirolimus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL | 1 |
Behbakht, K; Birrer, MJ; Burke, JJ; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Myers, AP; Pearl, M; Van Hummelen, P; Zhang, Y; Zweizig, S | 1 |
2 trial(s) available for megestrol acetate and sirolimus
Article | Year |
---|---|
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen | 2014 |
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Topics: Class I Phosphatidylinositol 3-Kinases; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Mutation; Phosphatidylinositol 3-Kinases; Prospective Studies; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sirolimus; Tamoxifen; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins | 2016 |
2 other study(ies) available for megestrol acetate and sirolimus
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |